Register Now

Late-Breaking Clinical Trials

Late-Breaking Clinical Trials

Late-Breaking Clinical Trials

First-in-Human Evidence. Real-World Dialogue. Immediate Impact.

Late-Breaking Clinical Trials (LBCT) debut at HRX Live 2026 as an inaugural program.

Presentations will spotlight First-in-Human and Early Feasibility studies at the moment they begin to influence thinking, discussion, and decision-making across electrophysiology and cardiovascular innovation.

Where New Evidence Meets Real-World Decision-Making

Presented live on the HRX Main Stage, the inaugural LBCT session will bring early clinical evidence into a collaborative, cross-disciplinary environment, connecting emerging data with the clinicians, researchers, industry leaders, and innovators shaping what comes next.

LBCT presentations will be focused on First-in-Human studies, including new data not previously presented at any another conference.

Accelerate Understanding What New Data Means — Now

Late-Breaking Clinical Trials at HRX Live are designed to:

  • Surface new and emerging clinical data, including First-in-Human experience
  • Connect evidence to real-world workflows, adoption, and implementation
  • Bring clinicians, industry, startups, and regulators into the same conversation

See Who’s Presenting

See the Presenters

Submissions for LBCT closed July 10, 2026

Presenting Late Breaking Clinical Trials at HRX Live offers a unique opportunity to:

  • Share early clinical evidence in a high-trust, collaborative setting

  • Engage directly with clinicians, industry leaders, and innovators

  • Receive real-time feedback and perspective beyond traditional scientific formats

  • Participate in conversations that influence adoption, integration, and next-step development

Only a select number of submissions will be chosen for Main Stage presentation. The cost to submit each LBCT is $175 for HRS members and $275 for non-members. Additional submission details and guidelines will are available in the Submission Guidelines.

Accepted LBCTs will be:

See the Teams

Frequently Asked Questions (FAQs)